Clinical trial
The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19
NCT05092698 is registered in ClinicalTrials.gov with Federal Research Clinical Center of Federal Medical & Biological Agency, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19
- Lead sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- January 31, 2022
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sars-cov2 infection